Inactive

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Bionique Testing Laboratories for the use of rapid RT-PCR testing provides state-of-the... The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Bionique Testing Laboratories for the use of rapid RT-PCR testing provides state-of-the-art technology through consistent determination of low levels of Mycoplasma contaminants (1-10 genomic copies), generation of growth curves by enrichment for sensitivity, and pan-species detection for the dozens of Mycoplasma species that could contaminate our 25 mammalian cell culture lines in weekly production and hybridoma lines that have never been tested prior. The PCR technology of Bionique was the only source that meet the rigorous standards for our program. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at qna3@cdc.gov by COB 25 August. 2023.